分级诊疗制度下我国高血压与糖尿病基本药物及用药分析.docVIP

分级诊疗制度下我国高血压与糖尿病基本药物及用药分析 　　[摘要] 本文通过查询各省市高血压和糖尿病基本药物目录及增补情况，分析增补药品重合率，对在分级诊疗制度下高血压和糖尿病基本药物的配备和使用进行分析。发现各省市高血压和糖尿病基本药物增补数量差异大，增补前5位的重合率分别达到44.8%和34.5%；用药频度和销售额与增补药品中重合率高的药品相比，具有增补共性。建议整合地方增补目录和国家目录，增加治疗效果明确、不良反应少、患者依从性高、日均药费比较低的药品；把出现频率较高或增补重合率高的药物调入下一版国家基本药物目录；缩小基层医疗机构与综合医院的基本药物目录品种差异；促进基本药物优先合理使用。 　　[关键词] 分级诊疗；高血压和糖尿病；基本药物；增补；重合率 　　[中图分类号] R95 [文献标识码] A [文章编号] 1673-7210（2017）10（b）-0137-04 　　Essential drugs of hypertension and diabetes and its drug analysis based on hierarchical medical system in China 　　LIU Shiyong1，2 ZHAI Yi1 WU Jing1 LIANG Xiaofeng3 　　1.Division of Non-Communicable Disease Control and Community Health， Chinese Center for Disease Control and Prevention， Beijing 102206， China； 2.The Hospital of Central University of Finance and Economics， Beijing 100081， China； 3.Chinese Center for Disease Control and Prevention， Beijing 102206， China 　　[Abstract] This paper checks essential medicine list and supplementary of hypertension and diabetes in some provinces， analyzes supplementary drugs coincidence rate as well as its equipment and use of hypertension and diabetes bases on hierarchical medical system in China， and finds that there is big difference in supplemented quantity of essential medicines in hypertension and diabetes， which top five of coincidence rate reaches 44.8% and 34.5%. The frequency of drug use and sales have supplemented in common compared with high coincidence rate of drugs in supplementary drugs. The paper suggests to integrate local supplement and national essential medicine list and then to increase drugs with effective treatment， less adverse reaction， high independence of patients and relatively low average daily expenses， and adjust high frequency or supplemented high coincidence rate of drugs to the next version of national essential medicine list， so as to narrow the difference of essential medicines list between the grassroots medical institutions and general hospitals， and promote the priority of essential drugs. 　　[